Investigational Site Number 410001

Seoul 138-736

0 studies enrolling now · 9 studies all time

What they study most

Acute Coronary Syndrome, Cancer, Hematopoietic Neoplasm, Multiple Sclerosis Relapse, Non-small Cell Lung Cancer, Prostate Cancer, Rheumatoid Arthritis, Small Cell Lung Cancer, Type 2 Diabetes Mellitus, Venous Thromboembolism

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH) — Completed
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications — Completed
• Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer — Completed
• Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy — Completed
• Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer — Completed
• Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer — Completed
• Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta — Stopped early
• Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy — Completed